Sign inJoin free

Watch / CEOs & MDs

Rhinomed sniffs out opportunities in Victoria

13 Sept 20214:25

Rhinomed sniffs out opportunities in Victoria

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Michael Johnson, CEO of Nasal tech company Rhinomed joins ausbiz to discuss its deal with the Victorian Government for 1 million of its COVID-19 nasal swabs. Rhinomed's technology improves the sample collection process, says Michael, and not only is it more comfortable and easier to use than the standard COVID-19 nasal swab, but it captures a larger sample and can accelerate the sample collection process. Michael says the swap can be self-administered, significantly reducing queues and waiting times. There have been well over two billion COVID-19 tests carried out globally over the past 18 months, and close to 26 million in Australia. There is a major opportunity for Rhinoswab to radically improve the testing process and user experience, and the company looks forward to working with the Victorian Department of Health. The revenue associated with its order with the Victorian government represents approximately 35-45% of the company's FY21 revenues of $3.9 million. Where else is the company looking for opportunities?

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy